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Dendritic cells (DCs) sense viral infections 
through a subset of nucleic acid–recognizing 
Toll-like receptors (TLRs) expressed in endo-
somal compartments (Akira et al., 2006). These 
receptors include TLR3, which detects double-
stranded viral RNA (Alexopoulou et al., 2001); 
TLR7 and TLR8, which recognize guanosine- 
and uridine-rich single-stranded RNA (ssRNA) 
(Diebold et al., 2004; Heil et al., 2004; Lund 
et al., 2004); and TLR9, which recognizes the 
phosphodiester backbone in natural DNA or 
unmethylated CpG motifs (Hemmi et al., 2000; 
Haas et al., 2008). TLR7 and TLR9 are se-
lectively  expressed  by  human  plasmacytoid 
dendritic cells (pDCs) (Jarrossay et al., 2001; 
Kadowaki et al., 2001; Hornung et al., 2002), a 
subset  of  dendritic  cells  specialized  in  type  I 
IFN production (Colonna et al., 2004; Gilliet 
et al., 2008). In contrast, classical human myeloid 
DCs (mDCs), which are potent stimulators of 
T cell responses by virtue of their inherent ca-
pacity to present antigens and migrate from the 
periphery into secondary lymphoid organs, do 
not express TLR7 and TLR9, but instead ex-
press TLR3 and TLR8 (Jarrossay et al., 2001; 
Kadowaki et al., 2001; Hornung et al., 2002).
Through  endosomal  TLRs,  pDCs  and 
mDCs efficiently sense viral nucleic acids but 
do not respond to self-nucleic acids released 
into  the  extracellular  environment  by  dying 
host cells. Structural differences such as the high 
levels  of  unmethylated  CpG  motifs  in  viral 
DNA and clusters of U or GU-rich sequences 
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Dendritic cell (DC) responses to extracellular self-DNA and self-RNA are prevented by the 
endosomal seclusion of nucleic acid–recognizing Toll-like receptors (TLRs). In psoriasis, 
however, plasmacytoid DCs (pDCs) sense self-DNA that is transported to endosomal TLR9 
upon forming a complex with the antimicrobial peptide LL37. Whether LL37 also interacts 
with extracellular self-RNA and how this may contribute to DC activation in psoriasis is not 
known. Here, we report that LL37 can bind self-RNA released by dying cells, protect it 
from extracellular degradation, and transport it into endosomal compartments of DCs. In 
pDC, self-RNA–LL37 complexes activate TLR7 and, like self-DNA–LL37 complexes, trigger 
the secretion of IFN- without inducing maturation or the production of IL-6 and TNF-. 
In contrast to self-DNA–LL37 complexes, self-RNA–LL37 complexes also trigger the activation 
of classical myeloid DCs (mDCs). This occurs through TLR8 and leads to the production of 
TNF- and IL-6, and the differentiation of mDCs into mature DCs. We also found that 
self-RNA–LL37 complexes are present in psoriatic skin lesions and are associated with 
mature mDCs in vivo. Our results demonstrate that the cationic antimicrobial peptide LL37 
converts self-RNA into a trigger of TLR7 and TLR8 in human DCs, and provide new insights 
into the mechanism that drives the auto-inflammatory responses in psoriasis.
© 2009 Ganguly et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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In psoriasis, a chronic autoimmune-inflammatory disease of 
the skin, self-DNA forms complexes with the cationic antimi-
crobial peptide LL37. Self-DNA–LL37 complexes gain access 
to endosomal TLR9, leading to an aberrant activation of pDCs 
to produce IFN- (Lande et al., 2007). pDC-derived IFN- 
initiates the autoimmune-inflammatory cascade in psoriasis, a 
process characterized by the activation of mDCs and their mat-
uration into DCs that stimulate pathogenic autoimmune T cells 
(Nestle et al., 2005). However, whether LL37 also interacts 
with extracellular self-RNA, and whether this pathway is in-
volved in the activation of mDCs in psoriasis, is unknown.
Here, we found that LL37 also forms complexes with extra-
cellular self-RNA. These complexes are highly protected from 
RNase degradation and gain access to the endosomal compart-
ments of both pDCs and mDCs. Self-RNA–LL37 complexes 
induce TLR7 activation in pDCs and trigger the secretion of 
IFN-. Self-RNA–LL37 complexes also trigger the direct acti-
vation of mDCs to secrete TNF- and IL-6 and differentiate 
into mature DCs. This maturation of mDCs is triggered by en-
dosomal TLR8 and is enhanced by the concomitant activation 
of pDCs to produce IFN-. In-vivo, self-RNA–LL37 com-
plexes are specifically found in psoriatic skin and the number of 
these complexes correlates with the presence of mature mDCs. 
The current findings identify self-RNA–LL37 complexes as en-
dogenous triggers of TLR7 and TLR8 in human DCs, and 
provide a new link between the expression of antimicrobial 
peptides and DC-mediated inflammation in psoriasis.
in viral RNA have been considered a key factor in the dis-
crimination between viral and self-nucleic acids (Krieg, 2002; 
Diebold et al., 2004; Heil et al., 2004). However, more re-
cently, it has become clear that this discrimination is mainly 
achieved  by  the  intracellular  localization  of  these  TLRs, 
which allows recognition of viral nucleic acids released into 
endosomal compartments by the endocytosed virus (Barton 
et al., 2006). In contrast, self-nucleic acids are rapidly de-
graded in the extracellular environment and fail to access en-
dosomal compartments spontaneously (Barton et al., 2006). 
Self-DNA and self-RNA can, however, become a potent 
trigger of pDC activation when they are aberrantly trans-
ported into TLR-containing endosomes in the context of 
autoimmunity. In systemic lupus erythematosus (SLE), self-
RNA  and  self-DNA  are  complexed  with  autoantibodies 
against the nucleic acid or nucleoproteins, which deliver   
the nucleic acids into endosomal compartments of pDCs   
via FcRII-mediated endocytosis (Rönnblom et al., 2003; 
Barrat et al., 2005; Means et al., 2005). As a result, pDCs are 
continuously activated to produce type I IFNs, which drives 
the  development  of  autoimmunity  and  disease  formation. 
This has been demonstrated in mouse models of SLE using 
TLR7- or TLR9-deficient mice or inhibitors for TLR7 and 
TLR9 (Leadbetter et al., 2002; Lau et al., 2005; Christensen 
et al., 2006; Barrat et al., 2007), and by a study showing that 
TLR7  gene  duplication  in  mice  induces  SLE-like  disease 
(Deane et al., 2007).
Figure 1.  LL37 converts self-RNA into a trigger of pDCs to produce IFN-. (A) IFN- produced by pDCs after stimulation with superna-
tants from dying (UV-irradiated) U937 cells, either alone or premixed with LL37. In some experiments, DNA and/or RNA was depleted from super-
natants of dying cells by pretreatment with DNase I (2,000 U/ml) and/or RNase A (50 µg/ml). Data are the mean ± SEM of four independent 
experiments. (B) IFN- produced by pDCs after stimulation with increasing concentrations of total human RNA purified from U937 cells (self-
RNA), either alone (closed circles) or premixed with LL37 (self-RNA–LL37; open circles) or the scrambled peptide GL37 (self-RNA+GL37; open 
squares). (C) IFN- produced by pDCs after stimulation with self-RNA or self-DNA (both at 5 µg/ml) alone or in complex with LL37 (self-RNA–LL37 
and self-DNA–LL37). Each symbol represents an independent experiment; horizontal bars represent the mean. (D) Flow cytometric analysis of 
stimulated pDCs for CD80 and CD86 surface expression. CpG-2006 (1 µM) was used as a control to induce pDC maturation. Data are representa-
tive of at least three independent experiments.JEM VOL. 206, August 31, 2009 
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We have previously demonstrated that LL37 can con-
vert self-DNA into a trigger of IFN- induction in pDCs 
(Lande et al., 2007). To confirm that LL37 can also interact 
with self-RNA and convert it into a trigger of IFN- pro-
duction, pDCs were stimulated with LL37 premixed with 
total human RNA extracted from U937 cells. U937-derived 
self-RNA induced dose-dependent IFN- production when 
mixed with LL37, but not when given alone or mixed with 
the scrambled peptide GL37 (Fig. 1 B). Similar to self-DNA 
(Lande et al., 2007), pDCs activated by self-RNA mixed 
with LL37 produced high levels of IFN- (Fig. 1 C), but 
did not produce TNF- or IL-6 (Fig. S1) or undergo matu-
ration as assessed by measuring the expression of costimu-
latory molecules CD80 and CD86 (Fig. 1 D). Importantly, 
self-RNA isolated from a variety of cell types and tissue 
samples from various types of skin pathologies induced 
RESULTS
LL37 converts nonstimulatory self-RNA into a trigger  
of pDC activation to produce IFN-
To determine whether the antimicrobial peptide LL37 enables 
pDCs to sense self-nucleic acids released by dying cells, we stim-
ulated pDCs with supernatants of UV-irradiated U937 cells, 
which undergo apoptosis and secondary necrosis with the re-
lease of self-DNA and self-RNA (Lövgren et al., 2004). The 
supernatants induced high levels of IFN- in pDCs when mixed 
with LL37, but not when given alone (Fig. 1 A). Depletion of 
DNA from the supernatants substantially inhibited IFN- in-
duction; however, this inhibition was partial (Fig. 1 A). Deple-
tion of RNA from the supernatants also led to partial inhibition, 
whereas the combined depletion of RNA and DNA completely 
abolished IFN- induction (Fig. 1 A). These results indicate that 
both self-DNA and self-RNA contributed to pDC activation.
Figure 2.  LL37 binds self-RNA and forms aggregated particles. (A) Confocal microscopy images of self-RNA–LL37 and self-DNA–LL37 complexes 
generated in vitro (top panels) or formed by mixing supernatant of dying U937 cells with LL37 (bottom panels) and stained with Ribogreen (which stains 
both RNA and DNA) and DAPI (which stains DNA exclusively). RNA and DNA complexes were detected as Ribogreen+/DAPI and Ribogreen+/DAPI+ 
complexes, respectively. Bar, 20 µm. (B) Scanning electron microscopy of self-RNA–LL37 complexes formed by self-RNA fragments (top panels) or the 
short ssRNA sequence ssRNA40 (bottom panels). Bars: (left panels) 10 µm; (right panels) 1 µm. (C) Number of self-RNA–LL37 complexes counted as visible 
precipitates by phase-contrast microscopy. Increasing concentrations of NaCl (10, 50, 100, 200, 500, and 1,000 mM) were used to dissolve the complexes. 
Data are representative of three independent experiments. (D) Confocal microscopy of self-RNAAlexa488–LL37 (top left panel) and self-RNA–LL37Tamra 
(bottom left panel), or self-RNAAlexa488–LL37Tamra complexes (right panels). Self-RNAAlexa488–LL37Tamra complexes did not appear in the green channel after 
excitation at 488 nm (top right quadrant) but did appear in the red channel (top left quadrant), suggesting FRET. Photobleaching of the red fluorochrome 
TAMRA with the 543 laser (bottom left quadrant) resulted in recovery of green fluorescence of the Alexa Fluor 488 fluorochrome in response to excitation 
at 488 nm (bottom right quadrant). Numbers on the top of the right panels indicate excitation/emission wavelength. Bars: (left panels) 20 µm; (right 
panels) 10 µm.1986 DC SENSE SELF-RNA COUPLED WITH ANTIMICROBIAL PEPTIDE | Ganguly et al.
or self-RNA mixed with the control peptide GL37 were treated 
with RNase A and RNA was quantitated by a fluorometric 
assay at different time points. Whereas RNA alone and RNA 
mixed with GL37 were rapidly degraded, self-RNA–LL37 
complexes were highly resistant to degradation (Fig. 3 A). 
The ability of LL37 to protect RNA from RNase degrada-
tion was confirmed by agarose gel electrophoresis wherein 
we found that self-RNA in complex with LL37 was protected 
from digestion by RNase and was retained in the loading wells 
(Fig. 3 B). Thus, LL37 forms compacted self-RNA particles 
that are highly protected from extracellular degradation.
Self-RNA–LL37 complexes trigger endosomal TLR7 in pDC
To test whether LL37 can deliver self-RNA particles to 
TLR-containing endosomes, we stimulated pDCs with self-
RNAAlexa488 alone or in complex with LL37. After 4 h of 
stimulation, self-RNAAlexa488 was found to associate with 
pDCs when in complex with LL37 but not when given alone 
(Fig. 4 A). The self-RNA–LL37 complexes were internalized 
as indicated by confocal microscopy showing the intracellular 
location of the self-RNAAlexa488 (Fig. 4 B).
Because  pDCs  sense  RNA  through  endosomal  TLR7 
(Diebold et al., 2004; Heil et al., 2004; Lund et al., 2004), we 
examined whether TLR7 is involved in the recognition of 
self-RNA–LL37 complexes. IFN- induced in pDCs by self-
RNA–LL37 complexes was inhibited in a dose-dependent-
manner by bafilomycin, which blocks endosomal acidification 
and TLR signaling (Fig. 4 C). To specifically inhibit TLR7, 
we used the short oligonucleotide C661, which selectively 
blocks TLR7 (Barrat et al., 2005), as shown by the inhibition 
of IFN- induction by the synthetic TLR7 agonist R837 but 
not the TLR9 agonist CpG2006 (Fig. 4 D). Pretreatment of 
pDCs with C661 specifically blocked the IFN- induction 
by self-RNA–LL37 complexes (Fig. 4 D), indicating that 
similar levels of IFN- when mixed with LL37, indicat-
ing that cellular- or disease-dependent variations in RNA 
composition do not play a role in the responses to self-
RNA (Fig. S2). These data demonstrate that LL37 can 
convert otherwise nonstimulatory self-RNA into a trig-
ger of pDC activation to produce IFN-, and thus enable 
the RNA released during cell death to induce innate im-
mune activation.
LL37 binds self-RNA to form aggregated complexes  
that are protected from extracellular degradation
Interestingly, when total human RNA purified from U937 
cells was mixed with LL37 (but not GL37), we observed for-
mation of particulate complexes that ranged in size from 1 to 
30 µm that precipitated to the bottom of the culture plate. 
Fluorescence microscopy revealed that the visible complexes 
contained RNA, as they fluoresced when stained with Ribo-
green (which stains RNA preferentially, but also stains DNA) 
but not with DAPI (which stains DNA exclusively) (Fig. 2 A). 
At high magnification, the complexes had a characteristic bead-
like branched morphology (Fig. S3). Similarly, superna-
tants of dying U937 cells formed particulate complexes when 
mixed with LL37 but not with GL37. A large number of 
these complexes contained RNA given that they stained Ri-
bogreen+/DAPI (Fig. 2 A) and their formation was inhib-
ited by RNase pretreatment of the supernatants (Fig. S4). 
Interestingly,  visible  RNA  particles  were  more  abundant 
than  were  DNA  complexes  identified  as  DAPI+  particles 
(Fig. 2 A) that failed to form upon DNase pretreatment of the 
supernatants (Fig. S4). Further analysis of the RNA com-
plexes by electron microscopy revealed that the complexes 
consisted of aggregates of smaller electron-dense nanoscale 
particles with sizes ranging from 100 to 700 nm when total 
human RNA was used, and ranging from 100 to 300 nm 
when short ssRNA sequences were used (Fig. 2 B). RNA–
LL37 complexes were rapidly dissolved by addition of sodium 
chloride, indicating that ionic interactions between the cat-
ionic peptide and the negatively charged phosphate groups 
of the nucleic acid were involved in the formation of the 
complexes (Fig. 2 C).
A molecular interaction between RNA and LL37 was 
confirmed by fluorescence resonance energy transfer (FRET) 
between human RNA labeled with fluorescent dye Alexa 
488 (self-RNAAlexa488) and Tamra-labeled LL37 (LL37Tamra). 
Excitation of self-RNAAlexa488/LL37Tamra complexes at 488 nm 
did not elicit green fluorescence, but did result in red fluores-
cence of the complex owing to efficient energy transfer to 
Tamra. In contrast, after photobleaching of the Tamra fluo-
rophore at 543 nm, excitation at 488 nm could induce green 
fluorescence of the complexes, with a FRET efficiency of 
>90%, indicating a close molecular proximity between RNA 
and LL37 (Fig. 2 D).
Because free RNA is exquisitely sensitive to degradation 
by extracellular RNases, which may limit its intracellular 
delivery, we tested whether LL37 can protect self-RNA from 
nuclease activity. Self-RNA–LL37 complexes, self-RNA alone, 
Figure 3.  Self-RNA–LL37 complexes are protected from enzymatic 
degradation. (A) Self-RNA alone, self-RNA–LL37 complexes, or self-RNA 
mixed with the control peptide GL37 were treated with RNase A and 
quantified over 60 min by a fluorometric assay. The percentage of pro-
tection was calculated as the ratio of remaining RNA over the initial 
RNA input. Data are representative of at least three experiments.  
(B) Agarose gel electrophoresis of self-RNA alone and self-RNA–LL37 
complexes before and after RNase A treatment visualized by ethidium 
bromide staining.JEM VOL. 206, August 31, 2009 
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of CD80 and CD86 expression (Fig. 5, B and C, and Fig. S6). 
mDC activation by self-RNA–LL37 complexes was entirely 
dependent on self-RNA, given that these responses were abro-
gated by decreasing the amount of self-RNA in the com-
plexes (unpublished data). In contrast to self-RNA–LL37 
complexes, self-DNA–LL37 complexes were unable to acti-
vate mDCs (Fig. 5, A and B). In accordance with these find-
ings, stimulation of mDCs with supernatants of apoptotic 
cells combined with LL37 induced the secretion of proin-
flammatory cytokines, and this secretion was entirely depen-
dent on self-RNA because activity was abolished by depletion 
of self-RNA but not self-DNA (Fig. 5 D).
Because type I IFNs have been reported to directly stim-
ulate mDCs (Luft et al., 1998; Santini et al., 2000), we next 
investigated whether pDC-derived type I IFNs could en-
hance the activation and maturation of mDCs stimulated by 
self-RNA–LL37  complexes.  Compared  with  stimulation 
with either supernatant of activated pDCs or self-RNA–LL37 
alone, the combination of both significantly enhanced the 
activation of mDCs to secrete IL-6 and TNF- and enhanced 
their differentiation into mature CD83+ DCs (Fig. 6, A and B). 
pDC activation by self-RNA–LL37 complexes occurs through 
TLR7. In support of these data, we also found that short syn-
thetic ssRNA sequences that activate TLR7 in pDCs upon 
liposomal transfection (Diebold et al., 2004; Heil et al., 2004) 
were able to trigger IFN- production in pDCs when com-
plexed with LL37 (Fig. S5).
Self-RNA–LL37 complexes trigger maturation  
and production of proinflammatory cytokines in mDCs
Human mDCs do not express any TLR that can recog-
nize DNA, but they do express TLRs that recognize RNA 
(Kadowaki et al., 2001; Jarrossay et al., 2001; Hornung et al., 
2002). To test whether mDCs acquire the ability to respond 
to self-RNA when complexed with LL37, we stimulated im-
mature monocyte-derived mDCs or mDCs isolated directly 
from human peripheral blood with self-RNA or self-RNA–
LL37 complexes. Self-RNA–LL37 complexes but not self-
RNA alone activated mDCs to produce the proinflammatory 
cytokines TNF- and IL-6 (Fig. 5 A and Fig. S5), but not 
IFN- (Fig. S1). Self-RNA–LL37 complexes also activated 
mDCs to undergo maturation as shown by the up-regulation 
Figure 4.  LL37 transports self-RNA into pDCs to trigger endosomal TLR-7. (A) pDCs were stimulated for 4 h with self-RNAAlexa488 alone or self-
RNAAlexa488–LL37 and analyzed by flow cytometry for self-RNAAlexa488–containing pDCs. (B) Confocal microscopy of pDCs stimulated for 4 h with self-
RNAAlexa488–LL37 complexes and stained with Alexa 647–labeled anti–HLA-DR antibody to visualize the contour of the cell. (C) IFN- produced by pDCs 
stimulated with self-RNA–LL37 complexes after pretreatment with increasing concentrations of bafilomycin. (D) IFN- produced by pDCs after stimula-
tion with self-RNA–LL37, CpG-2006 (1 µM), or R837 (10 µg/ml) after pretreatment with 1 µM TLR7 inhibitor C661 or a control oligonucleotide (ctrl-ODN). 
Data in A–D are representative of at least three independent experiments; error bars in C and D represent the SD of triplicate wells.1988 DC SENSE SELF-RNA COUPLED WITH ANTIMICROBIAL PEPTIDE | Ganguly et al.
ized (Fig. 7 B). The cytokine production and the maturation 
of mDCs induced by self-RNA–LL37 complexes but not by 
the TLR4 agonist LPS was completely inhibited by bafilomycin 
in a dose-dependent manner (Fig. 7 C), demonstrating that 
mDC activation by self-RNA–LL37 complexes involved en-
dosomal TLR activation. Because mDCs express endosomal 
TLR3  and  TLR8  that  recognize  RNA,  we  investigated 
whether these TLRs are involved in sensing self-RNA–LL37 
complexes.  Using  293T  cells  transfected  with  TLR8  and 
TLR3 expression vectors along with a NF-B luciferase re-
porter plasmid, we found that self-RNA–LL37 complexes 
activated TLR8 but not TLR3 (Fig. 7 D). In support of this 
finding, we also found that synthetic short ssRNA sequences 
that activate TLR8 in human mDCs (Diebold et al., 2004; 
Heil et al., 2004) also activated mDCs when complexed with 
LL37 but not when given alone (Fig. S5).
Self-RNA complexes are present in psoriatic skin  
and are associated with mature mDCs
We have previously demonstrated that LL37 is highly ex-
pressed in the inflamed skin of psoriasis but is undetectable in 
inflamed skin of atopic dermatitis or in healthy skin (Lande et al., 
2007). To determine whether extracellular self-RNA–LL37 
complexes form in vivo, we stained skin sections with Ribo-
green and DAPI. We found numerous extracellular Ribo-
green+/DAPI complexes in the dermal compartment of 
psoriatic skin lesions, but not in skin of atopic dermatitis or 
healthy skin (Fig. 8, A and B). These tissue RNA complexes 
presented several features of self-RNA–LL37 complexes gen-
erated in vitro, including the size and bead-like branched 
structures resulting from the aggregation of smaller particles 
(Fig. 8, C–F).
To determine whether the self-RNA complexes in the 
tissues contained LL37, we first stained in vitro–generated 
self-RNA–LL37 complexes with an anti-LL37 antibody and 
Ribogreen (Fig. 8 G). Interestingly, we found that the anti-
body was able to stain these complexes but did not colocalize 
with the RNA stain, suggesting competition between bind-
ing of the antibody and staining with Ribogreen. Then, we 
stained self-RNA complexes in psoriatic tissues and found 
that the majority of these complexes contained LL37, al-
though the sites of antibody staining and the RNA stain did 
not colocalize (Fig. 8, H–J), as seen in the case of in vitro–
generated self-RNA–LL37 complexes. Importantly, psoriatic 
skin also contained substantial numbers of particulate self-
DNA–LL37 complexes (Fig. S7).
To determine whether the presence of tissue self-RNA 
complexes is associated with the presence of activated DCs in 
psoriatic skin, we stained serial sections of lesional psoriatic 
skin for RNA complexes and DC-LAMP, a lysosomal marker 
specific for mature mDCs. Consistent with previous reports 
(Lowes et al., 2005), we found large clusters of DC-LAMP–
positive mature mDCs (Fig. 8 O). We also found tissue 
self-RNA–LL37 complexes within these clusters, and, occa-
sionally, even inside the DCs as shown by the colocalization 
with endolysosomal compartments stained with DC-LAMP 
This activity was completely blocked by antibodies against 
IFN-, IFN- and IFN-R (Fig. 6 B). Thus, self-RNA–
LL37 complexes can trigger mDC activation and maturation, 
and this process is enhanced by the concomitant activation of 
pDCs to produce IFN-.
Self-RNA–LL37 complexes enter mDCs and trigger 
endosomal TLR8
As seen in pDCs, self-RNAAlexa488 was associated with mDCs 
when complexed with LL37 but not when given alone 
(Fig. 7 A). The self-RNA–LL37 complexes were internal-
Figure 5.  Self-RNA but not self-DNA in complex with LL37 acti-
vates mDCs to secrete TNF- and IL-6 and undergo maturation. 
Immature monocyte-derived mDCs were stimulated with self-RNA, self-
DNA, self-RNA–LL37, or self-DNA–LL37. (A) TNF- and IL-6 secretion was 
measured after overnight culture. Each symbol represents an independent 
experiment, and horizontal bars represent the mean. (B) Flow cytometry 
for surface expression of CD86 and CD80 on stimulated mDCs. LPS was 
used as a control to induce mDC maturation. (C) Mean fluorescence in-
tensity (MFI) changes for CD86 and CD80 expression on mDCs in response 
to stimulation with self-RNA–LL37 complexes. Each symbol represents an 
independent experiment, and horizontal bars represent the mean.  
*, P < 0.0005; paired Student’s t test. (D) TNF- production by mDCs stim-
ulated with supernatants of dying U937 cells, either alone or premixed 
with LL37. In some experiments, DNA and/or RNA was depleted from su-
pernatants of dying cells by pretreatment with DNase I and/or RNase A. 
Data indicate the mean ± SEM of three independent experiments.JEM VOL. 206, August 31, 2009 
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the peptide and the anionic phosphate backbone of RNA, 
similar to the phenomenon described for DNA (Lande et al., 
2007). In self-DNA–LL37 complexes, the -helical structure 
of LL37 appears to stabilize the interactions with the double-
stranded DNA (Lande et al., 2007). Because vertebrate RNA 
is single stranded, it is unclear whether the -helical structure 
of LL37 also plays a role in the formation and stabilization of 
complexes with RNA. It may be possible that LL37 prefer-
entially binds to regions where RNA folds into complex 
structures containing double-helical regions capped by hair-
pin or internal loops.
The mechanism by which LL37 converts nonstimulatory 
self-RNA into a trigger of TLR7 and TLR8 in DC involves 
two distinct steps. First, the binding of LL37 condenses free 
RNA into compacted structures that are highly protected 
from enzymatic degradation, a phenomenon that is critical 
for subsequent internalization of the complex. Second, by 
forming  these  complexes,  LL37  allows  the  association  of 
RNA with cellular membranes and the transport across these 
membranes into endocytic compartments. A previous study 
showed  that  DNA–LL37  complexes  acquire  net  positive 
charges that allow binding to anionic proteoglycans in the 
membrane of CHO cells followed by lipid raft–mediated en-
docytosis (Sandgren et al., 2004). Similarly, RNA–LL37 
(Fig. 8, K–N). The number of tissue self-RNA complexes 
significantly  correlated  with  the  numbers  of  DC-LAMP–
positive mDCs in psoriatic skin (Fig. 8 P). Together, these 
findings strongly support our in vitro data that self-RNA 
complexes can activate mDCs and suggest that this pathway 
is operational in psoriasis.
DISCUSSION
Dying host cells are a rich source of extracellular self-RNA. 
Yet, extracellular self-RNA normally does not lead to innate 
immune activation because it is rapidly degraded by RNases 
and fails to access endosomal compartments of DCs where 
TLR7 and TLR8 are located. Here, we found that extracellu-
lar self-RNA acquires the ability to trigger activation of TLR7 
and TLR8 in human DCs by forming a complex with the en-
dogenous  antimicrobial  peptide  LL37.  Previously,  we  had 
demonstrated that LL37 can form a complex with self-DNA, 
leading to TLR9 activation of pDCs to produce IFN- (Lande 
et al., 2007). The present study shows that LL37 and the for-
mation of RNA complexes also allow activation of classical 
mDCs, leading to the production of TNF- and IL-6 and dif-
ferentiation into mature DCs with T cell stimulatory activity.
The formation of complexes between LL37 and RNA is 
driven by ionic interactions between the cationic residues of 
Figure 6.  IFN- induced by concomitant pDC activation enhances maturation and cytokine production by mDCs. (A) Flow cytometry for CD86, 
CD80, and CD83 surface expression. Data are representative of at least three experiments. (B) TNF- and IL-6 secretion measured by ELISA. Each symbol 
represents an independent experiment, and horizontal bars represent the mean.1990 DC SENSE SELF-RNA COUPLED WITH ANTIMICROBIAL PEPTIDE | Ganguly et al.
complexes interact with heparan-sulfate–containing proteo-
glycans in the membranes of DCs, as indicated by the find-
ing  that  heparinase  pretreatment  significantly  reduced  the 
uptake of the RNA–LL37 complexes into both pDCs and 
mDCs (unpublished data).
Internalized self-RNA triggers the activation of TLR7 
and TLR8, which recognize uridine moieties common to 
both viral RNA and self-RNA (Diebold et al., 2006). Com-
pared with viral RNA, self-RNA is highly methylated and 
contains high numbers of pseudouridines, which have been 
shown to lack the ability to activate and rather inhibit TLR7 
and TLR8 activation (Karikó et al., 2005; Robbins et al., 
2007). Our finding that total cellular RNA isolated from 
cells or released by dying cells can trigger TLR7 and TLR8 
activation indicates that non-modified sequences in mam-
malian RNA are sufficient to induce immune activation if 
RNA is protected from extracellular degradation and trans-
ported  into  the  endosomal  compartments.  Accordingly, 
self-RNA has been previously found to trigger TLR7 activation 
if encapsulated into liposomes and transfected into DCs 
(Diebold et al., 2006).
Our study identifies self-RNA–LL37 complexes as small 
extracellular particles in inflamed skin of psoriatic patients, 
demonstrating that these complexes can form in vivo in the 
context of immunopathology. These tissue RNA particles 
were associated with the presence of mature mDCs, provid-
ing  evidence  that  self-RNA–LL37  particles  are  linked  to 
mDC activation in vivo. Psoriasis is characterized by an early 
skin infiltration of pDC and their aberrant activation to pro-
duce IFN- (Nestle et al., 2005). During later stages of the 
disease, however, psoriatic lesions are mainly characterized 
by large numbers of mature mDCs, which stimulate patho-
genic T cells, whereas pDCs are absent (Albanesi et al., 
2009). Based on our findings, we propose that self-RNA–LL37 
complexes may trigger a concerted activation of pDCs and 
mDCs, which initiate the inflammatory process during early 
psoriasis. During later stages of the disease, inflammation may 
be exclusively maintained by mDCs that are activated by self-
RNA–LL37 complexes.
LL37 expression is typically induced in epithelial cells or 
released by neutrophils in the context of tissue injury or in-
fection. Although the mechanisms controlling LL37 expres-
sion are still poorly understood, recent studies revealed the 
key involvement of the vitamin D3 and hypoxia response 
pathways, as well as the effect of various microorganisms on 
the production of LL37 (Liu et al., 2006; Schauber et al., 
2007; Peyssonnaux et al., 2008). In psoriasis, LL37 appears 
to be continuously overexpressed by lesional keratinocytes, 
leading to sustained formation of nucleic acid complexes that 
trigger TLR7, 8, and 9 in DCs. As a result, the uncontrolled 
activation of pDCs and mDCs may induce high levels of self-
antigen–specific T cells and the development of overt auto-
immunity.  In  contrast,  LL37  expression  in  common  skin 
wounds is short lived and may drive transient DC activation and 
inflammatory responses that participate in wound repair. It is 
possible that the transient LL37 expression and DC activation 
Figure 7.  LL37 transports self-RNA into mDCs and activates en-
dosomal TLR-8. (A) mDCs were stimulated for 4 h with self-RNAAlexa488 
alone or self-RNAAlexa488–LL37 and analyzed by flow cytometry for self-
RNAAlexa488–containing mDCs. (B) Confocal microscopy of mDCs stimu-
lated for 4 h with self-RNAAlexa488–LL37 complexes and stained with Alexa 
647–labeled anti–HLA-DR antibody to visualize the contour of the cell. 
Data in A and B are representative of at least five independent experiments. 
(C) TNF- and IL-6 secretion by mDCs stimulated with self-RNA–LL37 
complexes after pretreatment with increasing concentrations of bafilo-
mycin. Stimulation of the mDCs with LPS was used as negative control. 
Data are representative of three independent experiments. (D) NF-B 
promoter activity of TLR8- or TLR3-transfected HEK293 cells measured by 
luciferase reporter assay after stimulation at the indicated conditions. 
Data in D are the mean ± SEM of five independent experiments.  
*, P < 0.05; paired Student’s t test.JEM VOL. 206, August 31, 2009 
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Figure 8.  Extracellular RNA complexes are present in psoriatic skin and associated with mDC activation. (A) Confocal microscopy image of a 
representative psoriatic skin lesion stained with DAPI (red) and Ribogreen (green). DNA in cell nuclei appears yellow (Ribogreen+/DAPI+), and arrowheads 
indicate extracellular RNA aggregates appearing green (Ribogreen+/DAPI). Bar, 50 µm. (B) Numbers of visible extracellular RNA aggregates in the dermal 
compartment of healthy skin (n = 9), psoriatic skin (n = 11), and atopic dermatitis (n = 10). **, P = 0.0295; *, P = 0.042; unpaired Student’s t test (both 
two-tailed). (C–F) High magnification images of extracellular RNA aggregates in the dermal compartment of psoriatic skin lesions. Bar, 10 µm.  
(E and F) SFP projection of panel D. (G-I) Representative confocal microscopy images of in vitro–generated self-RNA–LL37 complexes (G), and tissue self-
RNA–LL37 aggregates stained with Ribogreen (green) and an anti-LL37 antibody (red) (H-I). Bars, (G) 10 µm; (H and I) 2 µm. (J) SFP projection of panel I. 
(K-N) Confocal microscopy images of DC-LAMP+ mature mDCs (red) in the dermal compartment of a representative psoriatic skin lesion co-stained with 
DAPI (blue) and Ribogreen (green). The images depict DC-LAMP (K), DAPI (L), and the merged image of DAPI and Ribogreen (M). (N) Merged image show-
ing the colocalization of RNA complexes (Ribogreen+/DAPI; green) with DC-LAMP–positive organelles (red) appearing yellow (N). Bar, 10 µm. (O) Immuno-
histochemical results for DC-LAMP in a representative psoriatic skin lesion. Bar, 50 µm. (P) Correlation between the numbers of DC-LAMP+ mDCs and the 
numbers of visible extracellular RNA aggregates in multiple psoriatic skin lesions (n = 11). Pearson R = 0.615, two-tailed P = 0.044. SFP, simulated fluores-
cence projection.1992 DC SENSE SELF-RNA COUPLED WITH ANTIMICROBIAL PEPTIDE | Ganguly et al.
in skin wounds may induce low levels of self-antigen–specific 
T cells; however, they are not sufficient to drive overt auto-
immunity. Indeed, a recent report has shown that T cells are 
activated during tissue damage and participate in wound re-
pair (Toulon et al., 2009). It is also possible that the short-
lived DC activation allows only activation of T cells that 
recognize high avidity antigens, such as those derived from 
pathogens invading the wounded tissue.
Persistent high levels of LL37 have also been reported in 
other chronic inflammatory diseases such as rosacea (Yamasaki 
et al., 2007), rheumatoid arthritis (Paulsen et al., 2002), colitis 
ulcerosa (Schauber et al., 2006), chronic nasal inflammatory 
disease (Kim et al., 2003), sarcoidosis (Agerberth et al., 1999), 
and cystic fibrosis (Bucki et al., 2007). Self-RNA–LL37 and 
self-DNA–LL37 complexes may also sustain the pathogenic 
inflammatory responses through TLR-mediated activation of 
DCs in these diseases, as we found in psoriasis. Thus, strate-
gies to inhibit the expression of LL37 or the formation of 
LL37–nucleic  acid  complexes  should  be  explored  for  the 
treatment of these diseases.
MATERIALS AND METHODS
Collection of human samples. Studies were approved by the Institutional 
Review Board for human research at the University of Texas M.D. Ander-
son Cancer Center in Houston and the Heinrich-Heine University in Düs-
seldorf. Skin specimens were obtained by 6-mm punch biopsies from normal 
skin of healthy subjects and from lesional skin of patients with chronic plaque 
psoriasis and atopic dermatitis, defined according to standard clinical and 
histopathological criteria. Cryosections were prepared from the biopsy spec-
imens and total RNA from homogenized skin specimen was extracted using 
standard protocols.
Reagents.  The  synthetic  peptide  LL37  (LLGDFFRKSKEKIGKE-
FKRIVQRIKDFLRNLVPRTES) and the corresponding scrambled control 
peptide GL37 (GLKLRFESKIKGEFLKTPEVRFRDIKLKDNRISVQR) 
were purchased from Innovagen. LyoVec-free ssRNA sequences ssRNA40   
(5-GsCsCsCsGsUsCsUsGsUsUsGsUsGsUsGsAsCsUsC-3 [“s” denotes phos-
phothioate linkage]) and ssPolyU (single-stranded poly-uridine) were from 
InvivoGen and used at a final concentration of 5 µg/ml. The TLR9 agonist 
CpG-2006 (5-tcgtcgttttgtcgttttgtcgtt-3) was produced by Trilink and used 
at 1 M. Synthetic TLR7 agonist R837 (10 µM) and TLR8 agonist R848 
(100 ng/ml) were both from InvivoGen. The specific human TLR7 in-
hibitor C661 and the control oligonucleotide sequence (ctrl-ODN, 5-tcct-
gcaggttaagt-3) were from Dynavax and used at 1 µM to pretreat pDCs for 
30  min  at  37°C  before  stimulation.  Bafilomycin  was  obtained  from 
Sigma-Aldrich.
Isolation and generation of pDCs and mDCs. pDCs were isolated from 
buffy coats from healthy volunteers with anti–BDCA-4 microbeads (Miltenyi 
Biotec) and were sorted by FACS Aria (BD Biosciences) according to their 
lineage-negative, CD11c CD4+ phenotype. Immature mDCs were gener-
ated from blood monocytes obtained from peripheral blood mononuclear 
cells (PBMCs) using anti-CD14 microbeads (Miltenyi Biotec) and cultured 
for 5 d with GM-CSF and IL-4 (both from R&D Systems). Blood mDCs 
were isolated from PBMCs using anti-CD1c microbeads (Miltenyi Biotec).
In vitro generation and characterization of RNA–LL37 and DNA–
LL37 complexes. Total human RNA (self-RNA) and genomic DNA (self-
DNA) were extracted from cell lines or inflammatory skin samples using 
standard procedures. Skin samples used were 6-mm punch biopsies previ-
ously described (Lande et al., 2007). For the generation of complexes, 10 µg 
of LL37 was mixed with 1 µg of self-RNA or self-DNA in 20 µl of PBS. 
Culture supernatant of necrotic cells was generated by an overnight culture 
of UV-irradiated (480 mJ/cm2 for 30 min) U937 cells (50 × 106/ml). For the 
generation of complexes, 100 µl of these supernatants was mixed with 10 µg 
of LL37. RNA and DNA complexes were visualized by confocal micros-
copy after staining with Ribogreen (1:100,000; Invitrogen) and DAPI (0.1 
ng/ml; Sigma-Aldrich). In some experiments the supernatants were treated 
with DNase I (2,000 U/ml), RNase A (50 µg/ml), or both.
To detect LL37, suspensions containing precipitating complexes were 
stained with 10 µg/ml mouse anti-LL37 antibody (clone 3d11; HyCult Bio-
technology) for 2 h, followed by careful washes and incubation with Alexa 
647–labeled anti–mouse secondary antibody for 1 h. After further washes, 
Ribogreen was added and the particulate complexes were visualized by con-
focal microscopy.
For FRET analysis, complexes were generated using self-RNA labeled 
with Alexa 488 (self-RNAAlexa488) using the Ulysis Nucleic Acid Labeling kit 
(Invitrogen) and Tamra-labeled LL37 (LL37Tamra; Innovagen). For scanning 
electron microscopy of the complexes, suspensions were air-dried overnight 
on poly-l-lysine–coated coverslips and then mounted onto double-stick car-
bon tabs (Ted Pella, Inc.) that had been previously mounted on to aluminum 
specimen mounts (Electron Microscopy Sciences). The samples were then 
coated under vacuum using an evaporator (Balzer MED 010; Technotrade 
International) with platinum alloy to a thickness of 25 nm followed by flash 
carbon coating. Samples were examined in a scanning electron microscope 
(model JSM-5910; JEOL USA, Inc.) at an accelerating voltage of 5 kV.
Stimulation and analysis of pDCs and mDCs. Suspensions (20 µl) con-
taining RNA–LL37 and DNA–LL37 complexes, or 100-µl supernatants of 
dying cells were added to pDC and mDC cultures in a final volume of 200 µl. 
After overnight culture, supernatants of pDCs and mDCs were collected and 
IFN- (PBL Biomedical Laboratories), IL-6, and TNF- (both from R&D 
Systems) were measured by ELISA. pDCs and mDCs were also stained with 
fluorochrome-labeled  anti-CD80,  anti-CD86,  and  anti-CD83  antibodies 
(BD Biosciences) and analyzed by flow cytometry. mDCs were also cultured 
with supernatant of pDCs stimulated for 24 h with self-DNA–LL37. In some 
cases, pDC supernatants were treated with a combination of anti–human 
IFN- (104 U/ml) antibodies, anti–human IFN- (2 × 103 U/ml) antibodies, 
and anti–human IFN- receptor antibodies (clone: MMHAR-2; 10 µg/ml) 
to block type I IFN activity (all from PBL Biomedical Laboratories).
Nuclease protection assays. The suspension containing RNA–LL37 com-
plexes were incubated with 50 µg/ml RNase A at 37°C. Then RNA in the sus-
pensions was stained with Ribogreen (Invitrogen) and quantitated by fluorimetry 
at different time points. In other experiments the suspensions, either RNase 
treated or left untreated, were run on a 1% agarose gel (with ethidium bromide) 
and imaged in a UV transilluminator gel imager (Bio-Rad Laboratories).
Uptake of self-RNA–LL37 complexes in pDCs and mDCs. pDCs or 
mDCs were stimulated with self-RNAAlexa488 alone or with self-RNAAlexa488–
LL37 complexes. After 4 h, cells were analyzed by flow cytometry. For confo-
cal  microscopy,  pDCs  and  mDCs  were  stimulated  with  self-RNAAlexa488–LL37Tamra 
complexes. After 4 h of stimulation, cells were stained with Alexa 647-conju-
gated anti–HLA-DR (BioLegend) and the slides were mounted in Prolong 
Gold Antifade mounting medium (Invitrogen).
Luciferase reporter assay. HEK293 cells were transiently transfected with 
500 ng of TLR3-GFP or TLR8-HA expression vectors (both from Invivogen) 
and 100 ng of NF-B luciferase reporter plasmid. The Renilla luciferase 
reporter gene (pRL-TK) was simultaneously transfected (5 ng) as an internal 
control for transfection efficiency. 24 h later, cells were collected and stimu-
lated as indicated for 24 h. Poly I:C and ssPolyU complexed with cationic 
lipids (DOTAP; Roche) were used as positive controls for the activation of 
TLR3 and TLR8, respectively. Luciferase activity was measured with a 
dual-luciferase reporter assay system (Promega).
Tissue immunofluorescence and immunochemistry. Immunofluores-
cence of DNA and RNA complexes was done on frozen sections of skin JEM VOL. 206, August 31, 2009 
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